| Literature DB >> 32308237 |
Allison May1, Loren Roustio1, Zachary A Hamilton1.
Abstract
In recent decades, there has been significant growth in the understanding of the immune system and its role in cancer. The recent introduction of checkpoint inhibitors has drastically changed the treatment landscape of cancer as a whole. In this review, we discuss the major clinical developments of immunotherapy in urologic specific cancers, as well as address future directions in this field. Copyright 2020 by the Missouri State Medical Association.Entities:
Year: 2020 PMID： 32308237
Source DB: PubMed Journal: Mo Med ISSN： 0026-6620